Michel Abou Abdallah

Fertility Specialist | Clinical Professor of Reproductive Endocrinology Fellow in Reproductive Endocrinology and Andrology – McGill University, Montreal, Canada

Prof. Michel Abou Abdallah is an internationally recognized expert in reproductive medicine, with extensive contributions to infertility treatment, clinical research, medical education, and academic advancement across Canada, Lebanon, the Middle East, and Africa. A distinguished fellow in reproductive endocrinology and andrology from McGill University, he has authored and co-authored a significant number of peer-reviewed publications, solicited reviews, and popular medical articles. His work has been widely presented at national and international scientific meetings and featured in both academic journals and mainstream press. Prof. Abou Abdallah serves on the editorial boards of the Middle East Fertility Society Journal and the Fundamental and Clinical Medicine Journal. He is a Clinical Professor of Reproductive Endocrinology and an executive board and faculty member of the Canadian Foundation for Reproductive Medicine (Montreal/Toronto, Canada). He is currently the Executive Director of the Middle East Fertility Society (MEFS), which he founded and previously served as President. His leadership in the field has earned him numerous honorary recognitions, including:
• Honorary Member, Argentinian Fertility Society
• Honorary Member, ALMER – Latin American Association for Reproductive Medicine
• Honorary Member, AMMR – Mexican Association for Reproductive Medicine
• Honorary Member, Libyan Society for Infertility and Disease Treatment
• Honorary Professor, Kemerovo, Russia
Prof. Abou Abdallah is also an active member of ESHRE (European Society of Human Reproduction and Embryology) and ASRM (American Society for Reproductive Medicine), where he serves on the International Committee Board. Globally regarded as a leading authority in human reproduction, Prof. Abou Abdallah’s expertise spans gamete physiology, male infertility, and assisted reproductive technologies (ART).